文献速递腹部USCT

超声造影在肝脏囊实性病变诊断中的应用

Application of contrast-enhanced ultrasound in the diagnosis of liver solid-cystic lesions.
PubMed 文献 · Eur J Radiol · 2025-07-25

本研究回顾性分析157例肝脏囊实性病变的常规超声与超声造影特征,比较两者及超声造影与增强CT的诊断效能。常规超声诊断准确率为64.3%,超声造影为84.1%,差异有统计学意义(P<0.001);142例同时行超声造影与增强CT的病变中,超声造影准确率85.2%,增强CT为81.0%,两者差异无统计学意义(P=0.21)。

要点

  • 超声造影对肝脏囊实性病变的诊断准确率84.1%,高于常规超声的64.3%(P<0.001)。
  • 142例同时行超声造影与增强CT的病变中,超声造影准确率85.2%,增强CT为81.0%,差异无统计学意义(P=0.21)。
  • 本研究纳入157例肝脏囊实性病变,其中良性87例、交界性肿瘤8例、恶性62例。

核心结论

  • 超声造影在肝脏囊实性病变诊断中展现出显著前景,与常规超声相比进一步提高诊断准确率,在本研究中不劣于增强CT。

研究设计与样本

  • 回顾性研究,纳入2011年1月至2024年11月收治的157例肝脏囊实性病变患者,总结其临床特征、常规超声及超声造影特征,并将超声造影与常规超声和增强CT的诊断效能进行比较。

关键影像表现/征象

  • 157例病变中良性87例(肝脓肿37例、肝棘球蚴病30例、囊肿8例、其他良性病变12例),交界性肿瘤8例(胆管内乳头状肿瘤5例、黏液性囊性肿瘤3例),恶性肿瘤62例(转移性癌24例、肝细胞癌19例、肝内胆管癌14例、其他恶性肿瘤5例)。

诊断标准与关键数值

  • 常规超声诊断肝脏囊实性病变的准确率为64.3%(95%CI:56.7%-72.0%)。
  • 超声造影诊断肝脏囊实性病变的准确率为84.1%(95%CI:77.9%-90.5%),与常规超声差异有统计学意义(P<0.001)。
  • 142例同时行超声造影与增强CT检查的病变中,超声造影准确率为85.2%(95%CI:80.0%-90.9%),增强CT为81.0%(95%CI:74.7%-87.3%),差异无统计学意义(P=0.21)。

临床应用与阅片要点

  • 对于肝脏囊实性病变,超声造影较常规超声可提高诊断准确率,本研究中其诊断准确率与增强CT相比差异无统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Liver solid-cystic lesions are diverse in type, and accurate differential diagnosis is of great clinical significance. This study aimed retrospectively analyze the sonographic features of conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) in liver solid-cystic lesions, and to compare their diagnostic performance.

METHODS: A total of 157 patients with liver solid-cystic lesions diagnosed by US from January 2011 to November 2024 were retrospectively collected. The clinical features, US and CEUS features of 157 lesions were summarized. The diagnostic performance of CEUS was compared with US and contrast-enhanced computed tomography (CECT) in the evaluation of liver solid-cystic lesions.

RESULTS: This study included 157 lesions comprising 87 benign lesions (37 liver abscesses, 30 hepatic echinococcosis, 8 cysts, and 12 other benign lesions), 8 borderline tumors (5 intraductal papillary neoplasms of the bile duct and 3 mucinous cystic neoplasms), and 62 malignant tumors (24 metastatic carcinomas, 19 hepatocellular carcinomas, 14 intrahepatic cholangiocarcinomas, and 5 other malignant neoplasms).The diagnostic accuracy of US for liver solid-cystic lesions was 64.3 % (95 % confidence interval [CI]: 56.7 %- 72.0 %), while that of CEUS was 84.1 % (95 % CI: 77.9-90.5 %). The difference between the US and CEUS was statistically significant (P<0.001). Comparative analysis of 142 lesions examined with both CEUS and CECT, CEUS showed non-inferior accuracy to CECT (85.2 % [95 % CI: 80.0-90.9 %] vs 81.0 % [95 % CI: 74.7-87.3 %], P = 0.21).

CONCLUSION: CEUS demonstrates significant promise in the diagnosis of liver solid-cystic lesions. Compared with US, CEUS further enhances diagnostic accuracy and is not inferior to CECT in our study.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yuan Z, Li J, Shi Y, et al. Application of contrast-enhanced ultrasound in the diagnosis of liver solid-cystic lesions. Eur J Radiol. 2025. PMID: 40768959. doi:10.1016/j.ejrad.2025.112336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。